Consequently, the new era of cancer therapy, based on cancer genetics and genomics along with an improved knowledge on cancer hallmarks, has increased the interest of the therapeutic potential of targeting NF-kB in cancer [81]. The gene discussed is NFKB1; the disease is cancer.